This is an old revision of this page, as edited by Yobot (talk | contribs) at 22:14, 1 December 2010 (WP:CHECKWIKI error fixes + general fixes using AWB (7442)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 22:14, 1 December 2010 by Yobot (talk | contribs) (WP:CHECKWIKI error fixes + general fixes using AWB (7442))(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)| Mark Atikinson | |
|---|---|
 | |
| Nationality | American |
| Scientific career | |
| Fields | Medical research, Type 1 Diabetes |
| Institutions | University of Florida College of Medicine |
Dr. Atkinson is currently an Eminent Scholar for Diabetes Research at The University of Florida. He also is the co-Director for The Diabetes Center of Excellence at that institution. The author of over 200 publications, Dr. Atkinson is beginning his 25th year of investigation into the field of type 1 (insulin dependent) diabetes. Dr. Atkinson has been the recipient of multiple scientific and humanitarian based awards for these efforts. These include three from the Juvenile Diabetes Research Foundation (JDRF). The first was the Gerold and Gayla Grodsky award (2001) provided to the outstanding Ph.D. investigating type 1 diabetes. More recently, he was awarded the Mary Tyler Moore & S. Robert Levine M.D. award for translational research on type 1 diabetes (2004). Finally, he was the recipient of the JDRF’s Rumbough award for contributions to diabetes research (2005). Dr. Atkinson was also a recent recipient of the prestigious Eli Lilly Award for Outstanding Scientific Achievement from the American Diabetes Association (2004), a rare honor in type 1 diabetes from that organization. He has also been active in a leadership service to the type 1 diabetes community, with active administrative or advisory service to The Juvenile Diabetes Research Foundation, The American Diabetes Association, The National Institutes of Health, The Immunology of Diabetes Society, and a variety of companies from the pharmaceutical and biotech industry. Finally, Dr. Atkinson is known for spending time with persons with or caring for those with type 1 diabetes, addressing their questions and sharing his passion and desire to see a cure for the disease. Dr. Atkinson is currently the executive director for nPOD.
Selected Publications
Yip L, Su L, Sheng D, Pearl C, Atkinson M, Czseak M, Albert P. R, Collier A, Turley S J, Fathman C G, Creusot R J. (2009). Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetes. Nature immunology, 10:1026–1033.
Atkinson MA, Gianani R. (2009). The pancreas in human type 1 diabetes: providing new answers to age-old questions. Current opinion in endocrinology, diabetes, and obesity, 16(4), 279-85.
Bierschenk L, Alexander J, Wasserfall C, Haller M, Schatz D, Atkinson M (2009). Vitamin D levels in subjects with and without type 1 diabetes residing in a solar rich environment. Diabetes Care, 32(11), 1-3.
Lowe CE, Cooper JD, Brusko T, Walker NM, Smyth DJ, Bailey R, Bourget K, Plagnol V, Field S, Atkinson M, Clayton DG, Wicker LS, Todd JA. (2007). Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nature Genetics, 39(9):1074-82.
Vaarala O, Atkinson MA, Neu J. (2008). The “perfect storm” for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes, 57(10):2555-62.
Parker MJ, Xue S, Alexander JJ, Wasserfall CH, Campbell-Thompson ML, Battaglia M, Gregori S, Mathews CE, Song S, Troutt M, Eisenbeis S, Williams J, Schatz DA, Haller MJ, Atkinson MA. (2009). Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in NOD mice. Diabetes.
References
- http://diabetes.ufl.edu/research/research-2/atkinson-lab/
- http://diabetes.ufl.edu/research/research-2/atkinson-lab/publications/